CalciMedica, Inc. (CALC) stock
CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.22+0.03 (+2.52%)
Close on Nov 17, 2026Market cap $41.65MP/E –Yield –
CalciMedica ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
CalciMedica's ebitda for the twelve months ending Dec 31, 2023 was -$38.02M. For fiscal 2023 it was -$38.02M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$38.02M | – |
| FY2022 | Dec 31, 2022 | -$14.14M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$4.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.82M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.57M | – |
| Q1 FY2023 | Mar 31, 2023 | -$22.33M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.20M | – |
See a number that looks wrong?